Could fewer shots control hives just as well? new trial aims to find out
Disease control
Recruiting now
This study looks at whether people with chronic spontaneous urticaria (long-term hives) who are well-controlled on omalizumab every 4 weeks can switch to every 6 weeks without losing control. Forty adults will be randomly assigned to continue standard dosing or extend their injec…
Phase: PHASE4 • Sponsor: Simon Francis Thomsen • Aim: Disease control
Last updated Jun 26, 2026 19:04 UTC